Comorbid overweight/obesity and chronic pancreatitis exacerbate the dyslipidemia progression in type 2 diabetic patients Cover

.blurhash-client-img { display: none !important; }

Comorbid overweight/obesity and chronic pancreatitis exacerbate the dyslipidemia progression in type 2 diabetic patients

Endocrine Regulations

Volume 56 (2022): Issue 3 (July 2022)

By: Mariya Marushchak, Kateryna Kozak and Inna Krynytska

Open Access

|Jul 2022

Authors

Mariya Marushchak

marushchak@tdmu.edu.ua

Department of Functional and Laboratory Diagnostics, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

Kateryna Kozak

Department of Pediatrics N2, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

Inna Krynytska

Department of Functional and Laboratory Diagnostics, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

DOI: https://doi.org/10.2478/enr-2022-0018 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 168 - 177

Published on: Jul 13, 2022

Published by: Slovak Academy of Sciences, Mathematical Institute

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

type 2 diabetes mellitus,

overweight/obesity,

chronic pancreatitis,

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2022 Mariya Marushchak, Kateryna Kozak, Inna Krynytska, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 56 (2022): Issue 3 (July 2022)Next article